FIND and WHO look to quicken innovation and access for diagnostics

Non-governmental organisation The Foundation for Innovative New Diagnostics (FIND) and the World Health Organization (WHO) have signed a new Memorandum of Understanding that lays the foundation for accelerating innovation and achieving equitable access to quality diagnostics for people globally.

One year on from the historic resolution to strengthen diagnostics, and with FIND as co-lead of the Access to COVID-19 Tools (ACT) Accelerator diagnostics pillar, this new agreement marks a step change in a strengthened partnership between WHO and FIND to speed up both innovation and access to diagnostics, supporting countries to implement the World Health Assembly Resolution on diagnostics.

“We are proud to be signing this Memorandum of Understanding (MoU) with WHO, as quality and accessible diagnostic testing is the backbone of health systems, primary healthcare and health security,” said Dr Ayoade Alakija, Board Chair of FIND. “At a time when there have been three cases of H5N1 avian flu spillover events from cows to humans in the last month and an outbreak of mpox in the Democratic Republic of the Congo, the importance of diagnostic testing to identify outbreaks and quash them before they become major epidemics or even pandemics has never been more critical.”

“This MoU is a recognition of a long-standing relationship between FIND and WHO,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “It is much more than a formalisation of our collaboration, as it opens new avenues to jointly work together, save lives and improve health.”

Signed on 1 June 2024 at a ceremony attended by Dr Tedros Adhanom Ghebreyesus, Dr Yukiko Nakatani (Assistant Director-General) and Dr Ayoade Alakija (Board Chair of FIND), the MoU will also see the two organisations building new avenues to share knowledge and scale up critical activities to accelerate access to life-saving diagnostics.

The signing of this MoU formalises a long-standing partnership between WHO and FIND and marks a major milestone in the journey towards better health and well-being across the world. By leveraging the strengths and expertise of both WHO and FIND, this partnership promises to drive innovation on diagnostic tests and also improve access to the tests to reduce health inequalities, ultimately leading to a healthier future for people everywhere.


Latest Issues

The Power to Disrupt - Clinical Diagnostics Expo UK

15 Hatfields
16 September, 2024

Microbe Conference 2024

Crowne Plaza Hotel, Sheffield, UK
20-22 September, 2024

Cardiac Marker Dialogues: Cardiac Biomarkers in Real Time – Experiences and Opportunities

Hilton Glasgow, 1 William Street, Glasgow, Scotland, G3 8HT
26-27 September, 2024

The British Association for Cytopathology Annual Scientific Meeting

Aztec Hotel and Spa, Bristol, BS32 4TS
18 October, 2024

UK NEQAS: Navigating Quality Standards in Point of Care Testing

The Hyatt Regency Hotel, Birmingham, UK
23 October, 2024